Authors: Wong, ECC Maher, VE Hines, K Lee, J Carter, CS Goletz, T Kopp, W Mackall, CL Berzofsky, JA Read, EJ

Citation: Ecc. Wong et al., Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy, CYTOTHERAPY, 3(1), 2001, pp. 19-29

Authors: Marshall, MA Jankovic, D Maher, VE Sher, A Berzofsky, JA

Citation: Ma. Marshall et al., Mice infected with Schistosoma mansoni develop a novel non-T-lymphocyte suppressor population which inhibits virus-specific CTL induction via a soluble factor, MICROBES IN, 3(13), 2001, pp. 1051-1061

Authors: White, JD Wharfe, G Stewart, DM Maher, VE Eicher, D Herring, B Derby, M Jackson-Booth, PG Marshall, M Lucy, D Jain, A Cranston, B Hanchard, B Lee, CC Top, LE Fleisher, TA Nelson, DL Waldmann, TA

Citation: Jd. White et al., The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma, LEUK LYMPH, 40(3-4), 2001, pp. 287-294

Authors: Maher, VE Worley, BS Contois, D Smith, MC Kelley, MJ Stipanov, M Khleif, SN Goletz, T van den Broeke, L Mackall, C Helman, LJ Carbone, DP Berzofsky, JA

Citation: Ve. Maher et al., Mutant oncogene and tumor suppressor gene products and fusion proteins created by chromosomal translocations as targets for cancer vaccines, MED INTEL U, 24, 2000, pp. 17-39